Pregnancy and COVID‐19: pharmacologic considerations

Ultrasound in Obstetrics & Gynecology, 2021 - Wiley Online Library
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …
被引用次数：104 相关文章

Pregnancy and COVID-19: pharmacologic considerations.

R D'Souza, R Ashraf, H Rowe, J Zipursky… - … in Obstetrics & …, 2021 - europepmc.org
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …
[HTML] nih.gov

[HTML][HTML] Pregnancy and COVID‐19: pharmacologic considerations

R D'Souza, R Ashraf, H Rowe, J Zipursky… - … in Obstetrics & …, 2021 - ncbi.nlm.nih.gov
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …

Pregnancy and COVID-19: pharmacologic considerations

R D'Souza, R Ashraf, H Rowe, J Zipursky… - … in Obstetrics and …, 2021 - hero.epa.gov
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …

Pregnancy and COVID‐19: pharmacologic considerations

R D'Souza, R Ashraf, H Rowe, J Zipursky… - Ultrasound in Obstetrics …, 2021 - infona.pl
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …

Pregnancy and COVID-19: pharmacologic considerations

R D'Souza, R Ashraf, H Rowe… - … in obstetrics & …, 2021 - pubmed.ncbi.nlm.nih.gov
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …
[PDF] researchgate.net

[PDF][PDF] Pregnancy and COVID-19: Pharmacologic Considerations

R D'Souza, R Ashraf, H Rowe - Work - researchgate.net
As of August 16th 2020, Severe Acute Respiratory Syndrome-related Coronavirus-2 (SARS-
CoV-2) was responsible for 21.3 million cases of coronavirus disease (COVID-19) and …

Pregnancy and COVID-19: pharmacologic considerations.

R D'Souza, R Ashraf, H Rowe, J Zipursky… - … in Obstetrics & …, 2021 - europepmc.org
In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …